ACR TI-RADS showed favorable sensitivity and moderate specificity in risk stratification of thyroid nodules. The use of ACR TI-RADS could avoid a large number of unnecessary biopsies, although at the cost of a slight decline in sensitivity.
No takes yet. Share an insight, caveat, or question.
Li et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: